【摘 要】
:
Purpose: To assess complications, local tumor recurrences, overall survival (OS), and estimates of cost-effectiveness for multisite cryoablation (MCA) of oligometastatic renal cell carcinoma (RCC).Mat
【机 构】
:
Departments of Radiology ,Wayne State University
论文部分内容阅读
Purpose: To assess complications, local tumor recurrences, overall survival (OS), and estimates of cost-effectiveness for multisite cryoablation (MCA) of oligometastatic renal cell carcinoma (RCC).Materials and Methods: A total of 60 computed tomography-and/or ultrasound-guided percutaneous MCA procedures were performed on 72 tumors in 27 patients (three women and 24 rnen).Average patient age was 63 years.Tumor location was grouped according to common metastatic sites.Established surgical selection criteria graded patient status.Median OS was determined by Kaplan-Meier method and defined life-years gained (LYGs).Estimates of MCA costs per LYG were compared with established values for systemic therapies.Results: Total number of tumors and cryoablation procedures for each anatomic site are as follows: nephrectomy bed, 11 and 11; adrenal gland, nine and eight; paraaortic, seven and six; lung, 14 and 13; bone, 13 and 13; superficial, 12 and nine; intraperitoneal, five and three; and liver, one and one.A mean of 2.2 procedures per patient were performed, with a median clinical follow-up of 16 months.Major complication and local recurrence rates were 2% (one of 60) and 3% (two of 72), respectively.No patients were graded as having good surgical risk, but median OS was 2.69 years, with an estimated 5-year survival rate of 27%.Cryoablation remained cost-effective with or without the presence of systemic therapies according to historical cost comparisons, with an adjunctive cost-effectiveness ratio of $28,312-$59,554 per LYG.Conclusions: MCA was associated with very low morbidity and local tumor recurrence rates for all anatomic sites, with apparent increased OS.Even as an adjunct to systemic therapies, MCA appeared cost-effective for palliation of oligometastatic RCC.
其他文献
Computed Tomography (CT)-guided percutaneous cryoablation was performed in a 43-year-old patient with intractable epigastric abdominal pain caused by advanced adenocarcinoma of the pancreas and extens
Background: New therapies are needed for pancreatic cancer.Objective: To determine the feasibility and safety of a new endoscopic treatment.Secondary endpoints were to determine: effects on tumor grow
Pancreatic cancer has a grim prognosis, with a 5-year survival rate of only 5%, and is listed as one of the top 4 fatal cancers.Currently, surgery is considered the most effective way for complete rec
Aim: To examine whether thermo-perfusion of the bile duct and duodenum may protect these organs during cryoablation of adjacent pancreatic tissue.Study design: Cryoablation of the pancreatic tissue, a
Percutaneous cryoablation is considered to be a minimally invasive option for local treatment of cancer.Its efficacy is now being documented in many organs, including the prostate, liver, kidney and l
Background: Cryotherapy is a method of endoscopic mucosal ablation that involves delivery of a cryogen to result in tissue destruction by extreme low temperature.Its effects are influenced by the dosa
BACKGROUND: Various definitions of biochemical failure (BF) have been used to predict cancer recurrence following prostate cryoablation.However to date, none of these definitions have been validated f
Objective: To determine the current status of the literature regarding the clinical effi cacy and complication rates of cryoablation vs radiofrequency ablation in the treatment of small renal tumours.
Context: The purpose of this paper is to review current salvage cryoablation (SCA) outcomes in patients with locally recurrent prostate cancer (PCa) following primary radiation therapy.Objective: The
There has been a dramatic change in the way urologists approach the management of renal tumours in general and in particular for small renal masses.Nephron-sparing options were generally considered ma